BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25421668)

  • 1. Aberrant epigenetic modifications in radiation-resistant head and neck cancers.
    Lin HY; Huang TH; Chan MW
    Methods Mol Biol; 2015; 1238():321-32. PubMed ID: 25421668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The methylation of DNA repeat elements is sex-dependent and temporally different in response to X radiation in radiosensitive and radioresistant mouse strains.
    Newman MR; Sykes PJ; Blyth BJ; Bezak E; Lawrence MD; Morel KL; Ormsby RJ
    Radiat Res; 2014 Jan; 181(1):65-75. PubMed ID: 24397437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation as a biomarker for head and neck cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
    Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish as an In Vivo Model to Assess Epigenetic Effects of Ionizing Radiation.
    Kong EY; Cheng SH; Yu KN
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines.
    Kumar A; Rai PS; Upadhya R; Vishwanatha ; Prasada KS; Rao BS; Satyamoorthy K
    Int J Radiat Biol; 2011 Nov; 87(11):1086-96. PubMed ID: 21815748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.
    Lee M; Nam HY; Kang HB; Lee WH; Lee GH; Sung GJ; Han MW; Cho KJ; Chang EJ; Choi KC; Kim SW; Kim SY
    Cell Death Dis; 2021 Mar; 12(3):250. PubMed ID: 33674559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic perspective into head and neck cancer through in silico gene expression profiling of histone lysine methyltransferases.
    Biron VL; Dort JC
    J Otolaryngol Head Neck Surg; 2008 Jun; 37(3):366-72. PubMed ID: 19128641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic factors of individual radiosensitivity and adaptive capacity.
    Kravets AP; Sokolova DA
    Int J Radiat Biol; 2020 Aug; 96(8):999-1007. PubMed ID: 32396015
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer: Radiotherapy induces epigenetic changes.
    Stone L
    Nat Rev Urol; 2016 May; 13(5):241. PubMed ID: 27041209
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation-induced epigenetic alterations after low and high LET irradiations.
    Aypar U; Morgan WF; Baulch JE
    Mutat Res; 2011 Feb; 707(1-2):24-33. PubMed ID: 21159317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The epigenome. Target for innovative therapies in head and neck carcinoma].
    Leipold A; Hess J; Zaoui K
    HNO; 2015 Nov; 63(11):786-91. PubMed ID: 26489412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma.
    Lee JC; Lee WH; Min YJ; Cha HJ; Han MW; Chang HW; Kim SA; Choi SH; Kim SW; Kim SY
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1203-11. PubMed ID: 24661673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
    Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
    Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
    van den Broek GB; Wreesmann VB; van den Brekel MW; Rasch CR; Balm AJ; Rao PH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4386-91. PubMed ID: 17671120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.
    Stein-O'Brien G; Kagohara LT; Li S; Thakar M; Ranaweera R; Ozawa H; Cheng H; Considine M; Schmitz S; Favorov AV; Danilova LV; Califano JA; Izumchenko E; Gaykalova DA; Chung CH; Fertig EJ
    Genome Med; 2018 May; 10(1):37. PubMed ID: 29792227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of DNA methylation levels sensitizes doxorubicin-resistant breast adenocarcinoma cells to radiation-induced apoptosis.
    Luzhna L; Kovalchuk O
    Biochem Biophys Res Commun; 2010 Feb; 392(2):113-7. PubMed ID: 20034463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives.
    Miousse IR; Ewing LE; Kutanzi KR; Griffin RJ; Koturbash I
    Crit Rev Oncog; 2018; 23(1-2):1-11. PubMed ID: 29953365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis.
    Radhakrishnan R; Kabekkodu S; Satyamoorthy K
    J Oral Pathol Med; 2011 Oct; 40(9):665-76. PubMed ID: 21649736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.